## Abstract The enhancer of zeste homolog 2 (EZH2), a known repressor of gene transcription, has been reported to be associated with biological malignancy in several cancers. The potential oncogenic role of EZH2 and its clinical/prognostic significance, however, in esophageal squamous cell carcinom
A new proliferation marker, minichromosome maintenance protein 2, is associated with tumor aggressiveness in esophageal squamous cell carcinoma
✍ Scribed by Hiroyuki Kato; Tatsuya Miyazaki; Yasuyuki Fukai; Masanobu Nakajima; Makoto Sohda; Junko Takita; Norihiro Masuda; Minoru Fukuchi; Ryokuhei Manda; Hitoshi Ojima; Katsuhiko Tsukada; Takayuki Asao; Hiroyuki Kuwano
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 190 KB
- Volume
- 84
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract __TP53__ mutations are common in esophageal squamous cell carcinomas (SCC). To identify biological markers of possible relevance in esophageal SCC, we (__i__) searched for genes expressed in a p53‐dependent manner in TE‐1, an esophageal SCC cell line expressing the temperature‐sensitive
## Abstract It has been previously demonstrated that human carcinomas express interleukin‐2 receptor (IL‐2R) α, β, and γ chains. The β and γ chains of IL‐2R have intermediate binding affinity for IL‐2 and are responsible for the intracellular signaling cascades after IL‐2 stimulation. IL‐2Rα lacks